These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22581823)

  • 21. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial.
    Rowe BH; Bota GW; Fabris L; Therrien SA; Milner RA; Jacono J
    JAMA; 1999 Jun; 281(22):2119-26. PubMed ID: 10367823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 36-month study on the cost/utility of add-on omalizumab in persistent difficult-to-treat atopic asthma in Italy.
    Dal Negro RW; Tognella S; Pradelli L
    J Asthma; 2012 Oct; 49(8):843-8. PubMed ID: 22954018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe asthma in obese patients: Improvement of lung function after treatment with omalizumab.
    Oliveira MJ; Vieira M; Coutinho D; Ladeira I; Pascoal I; Ferreira J; da Silva JM; Carvalho A; Lima R
    Pulmonology; 2019; 25(1):15-20. PubMed ID: 30827349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Real-life" Efficacy and Safety Aspects of 4-Year Omalizumab Treatment for Asthma.
    Al-Ahmad M; Arifhodzic N; Nurkic J; Maher A; Rodriguez-Bouza T; Al-Ahmed N; Sadek A; Jusufovic E
    Med Princ Pract; 2018; 27(3):260-266. PubMed ID: 29414831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
    Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G
    Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical benefits of 7 years of treatment with omalizumab in severe uncontrolled asthmatics.
    Pace E; Ferraro M; Bruno A; Chiappara G; Bousquet J; Gjomarkaj M
    J Asthma; 2011 May; 48(4):387-92. PubMed ID: 21391878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of inhaled steroids on recovery from occupational asthma after cessation of exposure: an 18-month double-blind crossover study.
    Malo JL; Cartier A; Côté J; Milot J; Leblanc C; Paquette L; Ghezzo H; Boulet LP
    Am J Respir Crit Care Med; 1996 Mar; 153(3):953-60. PubMed ID: 8630579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of a soluble TNFalpha receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial.
    Morjaria JB; Chauhan AJ; Babu KS; Polosa R; Davies DE; Holgate ST
    Thorax; 2008 Jul; 63(7):584-91. PubMed ID: 18245148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Asthma and COPD - dosing recommendations at beginning and end of treatment].
    Grunze M; Petermann W
    Ther Umsch; 2008 Oct; 65(10):607-11. PubMed ID: 18821520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study.
    Pelaia C; Calabrese C; Barbuto S; Busceti MT; Preianò M; Gallelli L; Savino R; Vatrella A; Pelaia G
    Pulm Pharmacol Ther; 2019 Feb; 54():25-30. PubMed ID: 30414440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical efficacy of omalizumab in an elderly veteran population with severe asthma.
    Verma P; Randhawa I; Klaustermeyer WB
    Allergy Asthma Proc; 2011; 32(5):346-50. PubMed ID: 22195686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The eXpeRience registry: the 'real-world' effectiveness of omalizumab in allergic asthma.
    Braunstahl GJ; Chen CW; Maykut R; Georgiou P; Peachey G; Bruce J
    Respir Med; 2013 Aug; 107(8):1141-51. PubMed ID: 23721684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statistical cluster analysis of the British Thoracic Society Severe refractory Asthma Registry: clinical outcomes and phenotype stability.
    Newby C; Heaney LG; Menzies-Gow A; Niven RM; Mansur A; Bucknall C; Chaudhuri R; Thompson J; Burton P; Brightling C;
    PLoS One; 2014; 9(7):e102987. PubMed ID: 25058007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simvastatin in the treatment of asthma: lack of steroid-sparing effect.
    Cowan DC; Cowan JO; Palmay R; Williamson A; Taylor DR
    Thorax; 2010 Oct; 65(10):891-6. PubMed ID: 20861293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy of severe asthma.
    Firszt R; Kraft M
    Curr Opin Pharmacol; 2010 Jun; 10(3):266-71. PubMed ID: 20462794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma.
    Chipps BE; Newbold P; Hirsch I; Trudo F; Goldman M
    Ann Allergy Asthma Immunol; 2018 May; 120(5):504-511.e4. PubMed ID: 29409951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
    Hardy J; Baggott C; Fingleton J; Reddel HK; Hancox RJ; Harwood M; Corin A; Sparks J; Hall D; Sabbagh D; Mane S; Vohlidkova A; Martindale J; Williams M; Shirtcliffe P; Holliday M; Weatherall M; Beasley R;
    Lancet; 2019 Sep; 394(10202):919-928. PubMed ID: 31451207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of asthma: anti-inflammatory effects of antileukotrienes].
    Ukena D
    Med Klin (Munich); 1997 Dec; 92 Suppl 5():37-40. PubMed ID: 19479395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omalizumab decreases exacerbation frequency, oral intake of corticosteroids and peripheral blood eosinophils in atopic patients with uncontrolled asthma.
    Pelaia G; Gallelli L; Romeo P; Renda T; Busceti MT; Proietto A; Grembiale RD; Marsico SA; Maselli R; Vatrella A
    Int J Clin Pharmacol Ther; 2011 Dec; 49(12):713-21. PubMed ID: 22122813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of asthma control: the SERENA study.
    Corrado A; Renda T; Polese G; Rossi A;
    Respir Med; 2013 Nov; 107(11):1659-66. PubMed ID: 24045118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.